NL6612348A - - Google Patents

Info

Publication number
NL6612348A
NL6612348A NL6612348A NL6612348A NL6612348A NL 6612348 A NL6612348 A NL 6612348A NL 6612348 A NL6612348 A NL 6612348A NL 6612348 A NL6612348 A NL 6612348A NL 6612348 A NL6612348 A NL 6612348A
Authority
NL
Netherlands
Application number
NL6612348A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of NL6612348A publication Critical patent/NL6612348A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J31/00—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring
    • C07J31/006—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring not covered by C07J31/003
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/0055—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 the 17-beta position being substituted by an uninterrupted chain of at least three carbon atoms which may or may not be branched, e.g. cholane or cholestane derivatives, optionally cyclised, e.g. 17-beta-phenyl or 17-beta-furyl derivatives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/0055—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 the 17-beta position being substituted by an uninterrupted chain of at least three carbon atoms which may or may not be branched, e.g. cholane or cholestane derivatives, optionally cyclised, e.g. 17-beta-phenyl or 17-beta-furyl derivatives
    • C07J41/0061—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 the 17-beta position being substituted by an uninterrupted chain of at least three carbon atoms which may or may not be branched, e.g. cholane or cholestane derivatives, optionally cyclised, e.g. 17-beta-phenyl or 17-beta-furyl derivatives one of the carbon atoms being part of an amide group
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J43/00—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J43/003—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton not condensed
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J9/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J9/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane
    • C07J9/005—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane containing a carboxylic function directly attached or attached by a chain containing only carbon atoms to the cyclopenta[a]hydrophenanthrene skeleton

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
NL6612348A 1965-09-03 1966-09-01 NL6612348A (cs)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DESC037674 1965-09-03
DESC038090 1965-11-27

Publications (1)

Publication Number Publication Date
NL6612348A true NL6612348A (cs) 1967-03-06

Family

ID=25993310

Family Applications (1)

Application Number Title Priority Date Filing Date
NL6612348A NL6612348A (cs) 1965-09-03 1966-09-01

Country Status (5)

Country Link
US (1) US3539687A (cs)
CH (3) CH504425A (cs)
DE (2) DE1493169A1 (cs)
GB (1) GB1118976A (cs)
NL (1) NL6612348A (cs)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4088760A (en) * 1976-06-23 1978-05-09 Richardson-Merrell Inc. Testosterone 5α-reductase inhibitors
DE2839033A1 (de) * 1978-09-05 1980-03-13 Schering Ag 3-oxo-4-pregnen-20 alpha -carbonsaeure- derivate, ihre herstellung und verwendung
AT368759B (de) * 1980-05-12 1982-11-10 Henkel Kgaa Verfahren zur herstellung von neuen steroid-20carbons[ureverbindungen
USRE35053E (en) * 1985-09-12 1995-10-10 The Upjohn Company Amines useful in producing pharmaceutically active CNS compounds
US5099019A (en) * 1985-09-12 1992-03-24 Upjohn Company Amines useful in producing pharmaceutically active CNS compounds
US5382661A (en) * 1985-09-12 1995-01-17 The Upjohn Company Pyrazinylpiperazinyl steroids
US20100048912A1 (en) 2008-03-14 2010-02-25 Angela Brodie Novel C-17-Heteroaryl Steroidal CYP17 Inhibitors/Antiandrogens, In Vitro Biological Activities, Pharmacokinetics and Antitumor Activity
ES2552087T3 (es) * 2009-02-05 2015-11-25 Tokai Pharmaceuticals, Inc. Nuevos profármacos de inhibidores de CYP17 esteroidales/antiandrógenos
BR112015023098A2 (pt) 2013-03-14 2017-07-18 Univ Jefferson agentes de infrarregulação do receptor de andrógeno e usos dos mesmos
CN105636594A (zh) 2013-08-12 2016-06-01 托凯药业股份有限公司 使用雄激素靶向疗法用于治疗肿瘤性疾病的生物标记物

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2697107A (en) * 1951-06-20 1954-12-14 Hoechst Ag Process of preparing chloramines of the steroid series
US2886564A (en) * 1955-03-24 1959-05-12 Upjohn Co Quaternary steroidal enamine salts
US3038912A (en) * 1961-07-21 1962-06-12 Searle & Co 20(bets)-[(monoalkylamino)methyl]pregn-5-en-3beta-ols, esters corresponding and intermediates thereto
GB1095167A (en) * 1963-12-05 1967-12-13 Shalom Sarel Amino-steroids

Also Published As

Publication number Publication date
CH505805A (de) 1971-04-15
DE1493169A1 (de) 1969-06-04
GB1118976A (en) 1968-07-03
DE1493181A1 (de) 1969-06-26
CH504426A (de) 1971-03-15
CH504425A (de) 1971-03-15
US3539687A (en) 1970-11-10

Similar Documents

Publication Publication Date Title
BE676803A (cs)
BE676864A (cs)
BE664335A (cs)
BE665466A (cs)
BE666132A (cs)
BE666429A (cs)
BE669379A (cs)
BE669941A (cs)
BE671857A (cs)
BE674057A (cs)
BE674137A (cs)
BE674456A (cs)
BE674586A (cs)
BE674620A (cs)
BE674634A (cs)
BE674755A (cs)
BE676773A (cs)
BE675089A (cs)
BE675176A (cs)
BE675336A (cs)
BE675519A (cs)
BE675548A (cs)
BE675563A (cs)
BE675609A (cs)
BE661643A (cs)